# OnCo record ocular-adnexal-malt-lymphoma (cancer). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/cancers/ocular-adnexal-malt-lymphoma/>
  a schema:MedicalCondition ;
  onco:kind "cancer" ;
  schema:identifier "ocular-adnexal-malt-lymphoma" ;
  schema:name "Ocular adnexal MALT lymphoma"@en ;
  schema:alternateName "Ocular adnexal marginal zone lymphoma"@en, "OAMZL"@en, "Orbital lymphoma"@en, "Conjunctival lymphoma"@en, "Lacrimal gland lymphoma"@en, "Ocular adnexal lymphoma"@en, "Eyelid lymphoma"@en, "Salmon patch lymphoma"@en ;
  schema:description "A slow-growing MALT lymphoma of the tissues around the eye: the conjunctiva, the eye socket, the tear gland or the eyelid. It usually shows itself as a painless salmon-pink patch on the white of the eye or as an eye that has begun to bulge, and it is controlled in almost everybody, often by a short course of radiotherapy."@en ;
  schema:url <https://onco.cc/cancers/ocular-adnexal-malt-lymphoma/> ;
  schema:dateModified "2026-09-29"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/MALT_lymphoma> ;
  schema:citation <https://doi.org/10.1038/s41375-022-01620-2>, <https://doi.org/10.1016/j.adro.2025.101822>, <https://doi.org/10.1080/10428190601132105>, <https://doi.org/10.1038/s41433-020-01198-y>, <https://doi.org/10.1038/bjc.2015.94> ;
  onco:tag "heme", "lymphoma", "subtype-page" ;
  onco:related <https://onco.cc/cancers/malt-lymphoma/>, <https://onco.cc/cancers/marginal-zone-lymphoma/>, <https://onco.cc/cancers/gastric-malt-lymphoma/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/>, <https://onco.cc/cancers/primary-cutaneous-marginal-zone-lymphoma/> ;
  onco:technologies <https://onco.cc/technologies/histopathology-ihc/>, <https://onco.cc/technologies/imrt-igrt/> ;
  onco:drugs <https://onco.cc/drugs/rituximab/> ;
  onco:terms <https://onco.cc/terms/lymphoma-nodal-versus-extranodal/>, <https://onco.cc/terms/lymphoma-indolent-versus-aggressive/>, <https://onco.cc/terms/lymphoma-tx-radiotherapy/>, <https://onco.cc/terms/lymphoma-tx-watch-and-wait/>, <https://onco.cc/terms/lugano-classification/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-esmo-marginal-zone-lymphoma-zucca-ann-oncol-2020/> ;
  onco:standardOfCare <https://onco.cc/technologies/histopathology-ihc/>, <https://onco.cc/terms/lugano-classification/>, <https://onco.cc/technologies/fdg-pet/>, <https://onco.cc/terms/lymphoma-nodal-versus-extranodal/>, <https://onco.cc/technologies/imrt-igrt/>, <https://onco.cc/terms/lymphoma-tx-radiotherapy/>, <https://onco.cc/technologies/palliative-radiotherapy/>, <https://onco.cc/cancers/marginal-zone-lymphoma/>, <https://onco.cc/cancers/malt-lymphoma/>, <https://onco.cc/drugs/rituximab/>, <https://onco.cc/drugs/bendamustine/>, <https://onco.cc/terms/lymphoma-tx-watch-and-wait/>, <https://onco.cc/key-papers/paper-esmo-marginal-zone-lymphoma-zucca-ann-oncol-2020/> .